Medicare Enrolled
Dr. Moustapha Abidali, DO
Critical Care Medicine · Glendora, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Abidali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abidali?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Abidali
Dr. Moustapha Abidali is a critical care medicine specialist in Glendora, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Abidali performed 5,823 Medicare services across 2,865 unique beneficiaries.
Between the years covered by Open Payments, Dr. Abidali received a total of $3,957 from 30 pharmaceutical and/or device companies across 131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Abidali is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 2% volume in CA
$3,957 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,823
Medicare services
Top 2% in CA for critical care medicine
2,865
Unique beneficiaries
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~485 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,953 | $65 | $148 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,044 | $98 | $214 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
878 | $174 | $404 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
348 | $106 | $246 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
267 | $62 | $144 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
237 | $104 | $248 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
175 | $89 | $159 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
169 | $14 | $35 |
| Spirometry test A test that measures the amount of air you can exhale and how fast you can blow it out. The provider evaluates the results to check lung function. |
73 | $20 | $47 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
71 | $32 | $87 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
71 | $47 | $114 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
71 | $50 | $122 |
| Lung volume measurement test A test that measures the largest amount of air you can breathe in and out. It evaluates the total capacity of your lungs. |
70 | $13 | $35 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
63 | $28 | $69 |
| Hemoglobin measurement A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
54 | $5 | $16 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
49 | $24 | $47 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
43 | $118 | $297 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
37 | $56 | $159 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $75 | $165 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
32 | $109 | $448 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
31 | $141 | $364 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
22 | $147 | $369 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
19 | $112 | $219 |
| Emergent tracheostomy An emergency procedure to create an opening in the windpipe to insert a breathing tube, guided by an endoscope. |
12 | $114 | $290 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$3,957
Total received (2018-2024)
Avg $565/year across 7 years
Top 26% in CA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
131
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,957 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$471
2023
$610
2022
$522
2021
$191
2020
$137
2019
$1,547
2018
$477
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$241
Regeneron Healthcare Solutions, Inc.
$63
Boehringer Ingelheim Pharmaceuticals, Inc.
$52
AstraZeneca Pharmaceuticals LP
$30
Insmed, Inc.
$23
Abbott Laboratories
$22
Boston Scientific Corporation
$18
Philips North America LLC
$15
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$6
Top 3 companies account for 75.7% of 2024 payments
All-time payments by company (2018-2024) ›
Olympus Corporation of the Americas
$1,121
AstraZeneca Pharmaceuticals LP
$543
GlaxoSmithKline, LLC.
$526
Regeneron Healthcare Solutions, Inc.
$327
GENZYME CORPORATION
$166
Boehringer Ingelheim Pharmaceuticals, Inc.
$145
United Therapeutics Corporation
$140
Paratek Pharmaceuticals, Inc.
$125
Philips Electronics North America Corporation
$115
PORTOLA PHARMACEUTICALS, LLC
$109
Allergan Inc.
$93
Shionogi Inc
$67
Actelion Pharmaceuticals US, Inc.
$53
Janssen Pharmaceuticals, Inc
$47
Sunovion Pharmaceuticals Inc.
$42
Aries Pharmaceuticals, Inc.
$41
Bayer HealthCare Pharmaceuticals Inc.
$33
Gilead Sciences, Inc.
$32
Boston Scientific Corporation
$31
Teva Pharmaceuticals USA, Inc.
$26
Insmed, Inc.
$23
Abbott Laboratories
$22
Electromed, Inc.
$22
Grifols USA, LLC
$21
PORTOLA PHARMACEUTICALS, INC.
$20
Covidien LP
$17
Circassia Pharmaceuticals Inc
$17
Philips North America LLC
$15
Shire North American Group Inc
$11
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$6
Top 3 companies account for 55.4% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (9061) SRC Sol Space · ANDEXXA · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BEVYXXA · BREZTRI · DUPIXENT · ELEVIEW · FARXIGA · FASENRA · Fetroja · GENERAL BRONCHIAL THERMOPLASTY · GLASSIA · LONHALA MAGNAIR · LifeVest · NUCALA · NUZYRA · OFEV · OPSUMIT · ORENITRAM · Olympus EBUS Bronchoscopes · PROCLAIM · Prolastin-C Liquid · S&RC Und · SMARTVEST · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · Utibron · Ventilator · WaveWriter Alpha Prime 16 · XARELTO · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
59
Per 100K population
0.6
County median income
$87,760
Nearest hospital
EMANATE HEALTH FOOTHILL PRESBYTERIAN HOSPITAL
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Abidali is a mixed practice specialist, with above-average Medicare volume (top 2% in CA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Abidali experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Abidali performed 1,953 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abidali receive payments from pharmaceutical companies?
Yes. Dr. Abidali received a total of $3,957 from 30 companies across 131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abidali's costs compare to other critical care medicines in Glendora?
Dr. Abidali's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abidali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Glendora
Browse critical care medicines in Glendora ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in CA
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in CA
Which CA critical care medicines receive the most from drug and device companies.
By company
Olympus Corporation of the Americas Payments to Doctors
See all physicians who received payments from Olympus Corporation of the Americas.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology